EP1191975A4 - Verbesserung der t-zellimmunität - Google Patents

Verbesserung der t-zellimmunität

Info

Publication number
EP1191975A4
EP1191975A4 EP00916705A EP00916705A EP1191975A4 EP 1191975 A4 EP1191975 A4 EP 1191975A4 EP 00916705 A EP00916705 A EP 00916705A EP 00916705 A EP00916705 A EP 00916705A EP 1191975 A4 EP1191975 A4 EP 1191975A4
Authority
EP
European Patent Office
Prior art keywords
improvement
cell mediated
mediated immunity
immunity
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00916705A
Other languages
English (en)
French (fr)
Other versions
EP1191975A2 (de
Inventor
Richard Lennox Boyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norwood Immunology Ltd
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Publication of EP1191975A2 publication Critical patent/EP1191975A2/de
Publication of EP1191975A4 publication Critical patent/EP1191975A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP00916705A 1999-04-15 2000-04-17 Verbesserung der t-zellimmunität Withdrawn EP1191975A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP9778A AUPP977899A0 (en) 1999-04-15 1999-04-15 Improvement of t cell mediated immunity
AUPP977899 1999-04-15
PCT/AU2000/000329 WO2000062657A2 (en) 1999-04-15 2000-04-17 Improvement of t cell mediated immunity

Publications (2)

Publication Number Publication Date
EP1191975A2 EP1191975A2 (de) 2002-04-03
EP1191975A4 true EP1191975A4 (de) 2005-05-25

Family

ID=3813977

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00916705A Withdrawn EP1191975A4 (de) 1999-04-15 2000-04-17 Verbesserung der t-zellimmunität

Country Status (11)

Country Link
EP (1) EP1191975A4 (de)
JP (1) JP2002542174A (de)
KR (1) KR20020007371A (de)
CN (1) CN100376288C (de)
AU (2) AUPP977899A0 (de)
BR (1) BR0009712A (de)
CA (1) CA2370296A1 (de)
HK (1) HK1046249A1 (de)
NZ (1) NZ514975A (de)
WO (1) WO2000062657A2 (de)
ZA (1) ZA200108451B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086000A1 (en) * 1999-04-15 2002-07-04 Richard Boyd Stimulation of thymus for vaccination development
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AU2001295270B2 (en) * 2000-10-13 2007-08-09 Norwood Immunology Ltd Treatment of T cell disorders
AU2002216323C1 (en) * 2000-10-13 2008-05-29 Norwood Immunology Ltd Disease prevention by reactivation of the thymus
WO2002030256A2 (en) * 2000-10-13 2002-04-18 Monash University Diagnostic indicator of thymic function
IL155413A0 (en) * 2000-10-13 2003-11-23 Univ Monash Hematopoietic stem cell gene therapy
AU2002225245C1 (en) * 2000-10-13 2008-07-17 Norwood Immunology Ltd Improvement of graft acceptance through manipulation of thymic regeneration
AU2002216320C1 (en) * 2000-10-13 2008-04-03 Norwood Immunology Ltd Hematopoietic stem cell gene therapy
JP2004510795A (ja) * 2000-10-13 2004-04-08 モナッシュ・ユニバーシティ 胸腺の再生を操作することによる移植片受容の改善
IL155414A0 (en) * 2000-10-13 2003-11-23 Univ Monash Disease prevention by reactivation of the thymus
IL147138A0 (en) * 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
WO2004103271A2 (en) * 2003-04-18 2004-12-02 Norwood Immunology, Ltd. Disease prevention and vaccination prior to thymic reactivations
CA2699012A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
CA2840424C (en) * 2011-07-01 2022-02-01 Beckman Coulter, Inc. Regulatory t cells and methods of identifying, obtaining and using to treat immuno-based disorders
CN103235135B (zh) * 2013-04-26 2015-02-04 史其新 一种用于表征外周调节性t细胞抑制活性的特征细胞群的检测方法及其应用
AU2017358042A1 (en) * 2016-11-11 2019-05-30 Longeveron Inc. Methods of using human mesenchymal stem cells to effect cellular and humoral immunity
AU2019225151A1 (en) * 2018-02-23 2020-08-20 Duke University Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
US11819520B2 (en) 2018-02-23 2023-11-21 Duke University Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001176A1 (en) * 1986-08-18 1988-02-25 Bunge (Australia) Pty. Ltd. Regulating animal reproduction
WO1992019746A1 (en) * 1991-04-29 1992-11-12 Csl Limited Recombinant immunocastration vaccine and polypeptides useful for same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001176A1 (en) * 1986-08-18 1988-02-25 Bunge (Australia) Pty. Ltd. Regulating animal reproduction
WO1992019746A1 (en) * 1991-04-29 1992-11-12 Csl Limited Recombinant immunocastration vaccine and polypeptides useful for same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LANDSTRÖM M ET AL: "Apoptosis in rat prostatic adenocarcinoma is associated with rapid infiltration of cytotoxic T-cells and activated macrophages.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER. 2 MAY 1997, vol. 71, no. 3, 2 May 1997 (1997-05-02), pages 451 - 455, XP002322556, ISSN: 0020-7136 *
PLOSKER G L ET AL: "Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.", DRUGS. DEC 1994, vol. 48, no. 6, December 1994 (1994-12-01), pages 930 - 967, XP001202673, ISSN: 0012-6667 *

Also Published As

Publication number Publication date
HK1046249A1 (zh) 2003-01-03
WO2000062657A2 (en) 2000-10-26
AU779067B2 (en) 2005-01-06
WO2000062657A3 (en) 2001-01-11
BR0009712A (pt) 2002-04-30
CA2370296A1 (en) 2000-10-26
CN1364093A (zh) 2002-08-14
EP1191975A2 (de) 2002-04-03
KR20020007371A (ko) 2002-01-26
NZ514975A (en) 2004-03-26
AUPP977899A0 (en) 1999-05-13
JP2002542174A (ja) 2002-12-10
CN100376288C (zh) 2008-03-26
AU3797700A (en) 2000-11-02
ZA200108451B (en) 2003-01-15

Similar Documents

Publication Publication Date Title
EP1191975A4 (de) Verbesserung der t-zellimmunität
SG118147A1 (en) Inhibitors of alpha4 mediated cell adhesion
HK1034818A1 (en) Inverter
DE50008784D1 (en) Glas/kunststoff-compounds
AU141671S (en) Set of containers
HUP0201133A2 (en) Electrode structure
GB9919462D0 (en) Hydrocyclone
HK1120294A1 (en) Electrode
EP1218407A4 (de) Verwendungen von kappa-conotoxin pviia
PL351523A1 (en) Novel 8a- and 9a-15-membered lactams
GB2356365B (en) Centrifuge
EP1229795A4 (de) Menschliches chemokine beta-13
GB2355942B (en) Separator
GB9917205D0 (en) Separator
GB9913884D0 (en) Separator
TW412052U (en) Structure of switch
TW393983U (en) Structural improvement of stemware
TW394123U (en) Structure of emery-roller
TW468411U (en) Structure of cardcase
GB9902952D0 (en) Pepin
TW399438U (en) Improved structure of bedhead
TW410808U (en) Improved structure of garbage can
TW389046U (en) Structure of hairgrip combinations
GB9927799D0 (en) Electrodes
PL337258A1 (en) Separator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011105

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050412

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NORWOOD IMMUNOLOGY, LTD.

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1046249

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091103